Insulet Corp. (PODD)
295.18
+0.98
(+0.33%)
USD |
NASDAQ |
Dec 10, 16:00
295.75
+0.57
(+0.19%)
After-Hours: 16:43
Insulet Free Cash Flow: 407.70M for Sept. 30, 2025
Free Cash Flow Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
Free Cash Flow Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Free Cash Flow Benchmarks
| Boston Scientific Corp. | 3.824B |
| ResMed, Inc. | 1.757B |
| Baxter International, Inc. | 235.00M |
| Tandem Diabetes Care, Inc. | -25.12M |
| Masimo Corp. | 188.70M |
Free Cash Flow Related Metrics
| Cash from Operations (Quarterly) | 125.70M |
| Cash from Investing (Quarterly) | -31.00M |
| Cash from Financing (Quarterly) | -457.00M |
| Free Cash Flow Per Share (Quarterly) | 1.339 |
| Free Cash Flow to Equity (Quarterly) | 480.70M |
| Free Cash Flow to Firm (Quarterly) | 105.73M |
| Free Cash Flow Yield | 1.91% |